person

Zbigniew N.

Country
Poland
Department
Klinika Nowotworów Piersi i Chirurgii Rekonstrukcyjnej

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
579
Sites with multiple studies

Has run more than one trial at 579 of 912 partner sites.

Specializations

Advanced Breast Cancer Research

Specializes in investigating treatments for hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular focus on novel therapeutic combinations and targeted approaches.

  • Endocrine therapy resistance
  • Advanced metastatic disease
  • CDK4/6 inhibitor combinations

Explores innovative treatment pathways including targeted therapies like capivasertib and giredestrant.

Early-Stage Breast Cancer

Focuses on developing treatments for early-stage HER2-positive and triple-negative breast cancer, with emphasis on adjuvant and neoadjuvant therapeutic approaches.

  • Post-operative treatment optimization
  • High-risk disease management
  • Immunotherapy applications

Investigates novel therapeutic strategies including antibody-drug conjugates and targeted immunotherapies.

Precision Medicine Approaches

Specializes in biomarker-driven treatment strategies and personalized therapeutic approaches for breast cancer patients.

  • PIK3CA mutation targeting
  • ESR1 mutation analysis
  • Treatment resistance mechanisms

Conducts research on molecular profiling and targeted therapy selection for optimal treatment outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.